INFLECTRA (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the INFLECTRA drug offered from Pfizer Laboratories Div Pfizer Inc. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | infliximab-dyyb |
| SUBSTANCE NAME: | INFLIXIMAB, LICENSE HOLDER UNSPECIFIED |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-11-21 |
| END MARKETING DATE: | 0000-00-00 |
INFLECTRA HUMAN PRESCRIPTION DRUG Details:
| Item Description | INFLECTRA from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/10mL) |
| START MARKETING DATE: | 2016-11-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0809_ba28d344-9400-4361-a0cf-5e2fec19c1fc |
| PRODUCT NDC: | 0069-0809 |
| APPLICATION NUMBER: | BLA125544 |
Other INFLIXIMAB, LICENSE HOLDER UNSPECIFIED Pharmaceutical Manufacturers / Labelers:
